Invention Grant
- Patent Title: Targeting corroles for tumor toxicity and MRI
-
Application No.: US15624228Application Date: 2017-06-15
-
Publication No.: US10709801B2Publication Date: 2020-07-14
- Inventor: Lali K. Medina-Kauwe
- Applicant: Cedars-Sinai Medical Center
- Applicant Address: US CA Los Angeles
- Assignee: CEDARS-SINAI MEDICAL CENTER
- Current Assignee: CEDARS-SINAI MEDICAL CENTER
- Current Assignee Address: US CA Los Angeles
- Agency: Morrison & Foerster LLP
- Main IPC: A61K49/10
- IPC: A61K49/10 ; A61K31/555 ; A61K49/18 ; A61K33/24 ; A61K33/26 ; A61K33/32 ; A61K47/64 ; A61K9/16 ; A61K9/51

Abstract:
Disclosed herein are compositions comprising a targeted corrole nanoparticle; and an acceptable excipient. Also disclosed are compositions comprising a targeted corrole nanoparticle; and an acceptable carrier. Further, disclosed herein are methods of imaging a condition in a subject, comprising providing a composition comprising a targeted corrole nanoparticle; administering an effective amount of the targeted corrole nanoparticle to the subject; and imaging the condition in the subject. In addition, disclosed herein are methods of treating cancer in a subject, comprising providing a composition comprising a targeted corrole nanoparticle; and administering a therapeutically effective dosage of the targeted corrole nanoparticle to the subject.
Public/Granted literature
- US20170281802A1 TARGETING CORROLES FOR TUMOR TOXICITY AND MRI Public/Granted day:2017-10-05
Information query